{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:23:03Z","timestamp":1774621383365,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Since 1980, we have surveyed at 4-yr intervals the metropolitan health departments initially reporting &amp;gt; 250 cases of tuberculosis to determine the perceived standard of practice for tuberculosis control and the factors affecting formulation of treatment policies. Between 1992 and 1996, use of supervised short-course (6 to 9 mo) intermittent therapy with multiple drugs including isoniazid, ethambutol, pyrazinamide, and rifampin increased from 4.3% to 46% of all new patients. Pyrazinamide use for initial treatment for children has increased substantially and now predominates (74.2% of patients in 1996 versus 48.1% of patients in 1992). Duration of treatment, which was 20 \u00b1 2.1 mo in 1980, is now 8.00 \u00b1 2.29 mo in 1996. The incidence of human immunodeficiency virus\u2013associated tuberculosis, which was virtually unrecognized in 1984, has remained the same between 1992 and 1996 (18.0%). As in previous years, there was a wide variance among health departments in the incidence ( &amp;lt; 5% to &amp;gt; 40%) of HIV-associated tuberculosis. After years of funding decreases, there has been an impressive increase in resources in the past 4 yr. In 1988, mean budget allocation for health departments decreased by 7.9% versus the prior 4 yr and, in 1992, there was no overall change in budget allocation after inflation versus 1988. In 1996, however, funds for treatment increased by 84 \u00b1 33%. This increase in funding has been translated into the greatly expanded use of supervised intermittent therapy and aggressive screening programs, which likely have resulted in the decreased incidence of tuberculosis since the prior survey.<\/jats:p>","DOI":"10.1164\/ajrccm.156.5.9704105","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T13:26:14Z","timestamp":1365081974000},"page":"1487-1494","source":"Crossref","is-referenced-by-count":11,"title":["Tuberculosis Control Policies in Major Metropolitan Health Departments in the United States"],"prefix":"10.1093","volume":"156","author":[{"given":"DONNA R.","family":"LEFF","sequence":"first","affiliation":[{"name":"Medill School of Journalism and Institute for Policy Research, Northwestern University, Evanston; and Departments of Medicine and Pediatrics and the Committee on Clinical Pharmacology, Division of the Biological Sciences, The University of Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALAN R.","family":"LEFF","sequence":"additional","affiliation":[{"name":"Medill School of Journalism and Institute for Policy Research, Northwestern University, Evanston; and Departments of Medicine and Pediatrics and the Committee on Clinical Pharmacology, Division of the Biological Sciences, The University of Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1997,11,1]]},"reference":[{"key":"2026032709242569800_B1"},{"key":"2026032709242569800_B2","first-page":"745","article-title":"Tuberculosis chemotherapy practices in major metropolitan health departments in the United States.","volume":"144","author":"Leff","year":"1981","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0012-3692(15)37264-0","article-title":"Tuberculosis control practices in major metropolitan health departments in the Untied States. 3. Standard of practice in 1984.","volume":"87","author":"Leff","year":"1985","journal-title":"Chest"},{"key":"2026032709242569800_B4","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1164\/ajrccm\/139.6.1350","article-title":"Tuberculosis control policies in major metropolitan health departments in the United States. IV. Standards in 1988.","volume":"139","author":"Leff","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B5","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1530","article-title":"Tuberculosis control policies in major metropolitan health departments in the United States. V. Standards in 1992.","volume":"148","author":"Leff","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199101313240503","article-title":"Treatment of tuberculosis in patients with advanced human immunodeficiency infection.","volume":"324","author":"Small","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"2026032709242569800_B7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1164\/ajrccm\/144.4.745","article-title":"Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs.","volume":"144","author":"Brudney","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B8","first-page":"231","article-title":"An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus.","volume":"326","author":"Daley","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1164\/ajrccm\/139.1.4","article-title":"The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS).","volume":"139","author":"Horsburgh","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1164\/ajrccm\/146.2.285","article-title":"Incidence and natural history of Mycobacterium avium\u2013complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine.","volume":"146","author":"Chaisson","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1164\/ajrccm\/139.1.1","article-title":"Mycobacteria and AIDS mortality.","volume":"139","author":"Chaisson","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B12","first-page":"1","volume":"4","author":"Department of Health and Human Services, USPHS, Centers for Disease Control","year":"1996","journal-title":"TB Notes"},{"key":"2026032709242569800_B13"},{"key":"2026032709242569800_B14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1164\/ajrccm\/144.6.1357","article-title":"Isoniazid preventive therapy for tuberculosis: decision analysis considering ethnicity and gender.","volume":"144","author":"Jordan","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B15"},{"key":"2026032709242569800_B16","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1164\/ajrccm.155.5.9154885","article-title":"Rifampin preventive therapy for tuberculosis infection.","volume":"155","author":"Villarino","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032709242569800_B17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1164\/ajrccm\/143.2.257","article-title":"An outbreak of tuberculosis in a shelter for homeless men.","volume":"143","author":"Nolan","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B18","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1164\/ajrccm.155.5.9154881","article-title":"Validity of a decision tree for predicting active tuberculosis.","volume":"155","author":"El-Solh","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032709242569800_B19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1164\/ajrccm\/143.4_Pt_1.697","article-title":"Short-course chemotherapy of tuberculosis.","volume":"143","author":"Iseman","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-76-3-112-6-397","article-title":"USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity, acceptability.","volume":"112","author":"Combs","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"2026032709242569800_B21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-76-3-112-6-407","article-title":"A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis.","volume":"112","author":"Cohn","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"2026032709242569800_B22","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJM199106063242307","article-title":"Tuberculosis in patients with human immunodeficiency virus infection.","volume":"324","author":"Barnes","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"2026032709242569800_B23","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1164\/ajrccm\/144.4.750","article-title":"Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with \u201cstandard\u201d chemotherapy in Kinshasa, Zaire.","volume":"144","author":"Perriens","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709242569800_B24"},{"key":"2026032709242569800_B25"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/156\/5\/1487\/67448325\/ajrccm_156_5_1487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/156\/5\/1487\/67448325\/ajrccm_156_5_1487.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:24:35Z","timestamp":1774617875000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/156\/5\/1487\/8530924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11,1]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[1997,11,1]]},"published-print":{"date-parts":[[1997,11,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.156.5.9704105","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1997,11]]},"published":{"date-parts":[[1997,11,1]]}}}